{"@id":"https://bioecon.ru/technology/immunosuppressant-apis-cyclosporin-tacrolimus/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/immunosuppressant-apis-cyclosporin-tacrolimus/","json":"https://cn.bioecon.ru/api/v1/technology/immunosuppressant-apis-cyclosporin-tacrolimus/index.json"},"id":"immunosuppressant-apis-cyclosporin-tacrolimus","industries":[],"lang":"cn","links":{"suppliers":["https://bioecon.ru/companies/syncozymes/","https://bioecon.ru/companies/bontac-bio-engineering-co-ltd/","https://bioecon.ru/companies/sumitomo-chemical/","https://bioecon.ru/companies/fufeng-group/","https://bioecon.ru/companies/hydropars-industrial-group/","https://bioecon.ru/companies/klk-oleo/","https://bioecon.ru/companies/aum-enzymes-infinita-biotech/","https://bioecon.ru/companies/enzymaster/","https://bioecon.ru/companies/pow-bio/"]},"maturity":8,"name":"免疫抑制剂原料药（环孢素A与他克莫司）发酵生产","regions":["us","cn","eu","ru"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-15","entity":"ncbi.nlm.nih.gov","kind":"research","urls":["https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905321/"]},{"date":"2026-11-15","entity":"sciencedirect.com","kind":"research","urls":["https://doi.org/10.1016/j.biotechadv.2023.108250"]}],"stages":[{"n":1,"title":null},{"n":2,"title":null},{"n":3,"title":null},{"n":4,"title":null}],"summary":"采用代谢工程微生物发酵或多酶级联催化工艺的高纯度免疫抑制剂原料药（环孢素A与他克莫司）发酵生产工业化生物制造技术。以膨大弯颈霉产环孢素A，或筑波链霉菌发酵产他克莫司，调控长碳链有机酸补料与微量元素合成前体。。","url":"/technology/immunosuppressant-apis-cyclosporin-tacrolimus/","verified":"2026-11-15"}